SMYD2 Inhibition Attenuates Cisplatin-Induced Renal Fibrosis
2026-04-25
The referenced study demonstrates that pharmacological inhibition of SMYD2, specifically using LLY-507 or AZ505, mitigates renal fibrosis and inflammation in a cisplatin-induced chronic kidney disease model. These findings highlight SMYD2 as a promising epigenetic target for renal fibrosis intervention and provide mechanistic insight into its modulation of key signaling pathways relevant to fibrotic disease.
Intracellular Mechanisms of Aminopeptidase Inhibitors in Mye
2026-04-24
This study rigorously demonstrates that bestatin and actinonin inhibit myeloma cell proliferation primarily through intracellular mechanisms, rather than by targeting cell surface aminopeptidases. The research further shows that drug efflux pathways—including P-glycoprotein and MRP—modulate inhibitor potency, with implications for optimizing combination therapy and resistance studies.
O-GlcNAcylation Regulates Ferroptosis via HUWE1-TfR1 in Pree
2026-04-24
This study uncovers how O-GlcNAc protein modification stabilizes HUWE1, promoting TfR1 ubiquitination and degradation, thereby limiting iron uptake and ferroptosis in trophoblasts. These mechanistic insights reveal a pivotal pathway underlying syncytialization defects and oxidative stress in preeclampsia, suggesting novel research and therapeutic targets.
ER Stress and Cytokine Storms Drive Pro-metastatic Tumor Sta
2026-04-23
Conod et al. uncovered how tumor cells escaping near-lethal stress can adopt stable, prometastatic phenotypes—PAMEs—through ER stress signaling, reprogramming, and cytokine storm induction. These findings clarify the origins of metastatic potential in primary tumors and point to actionable targets for metastasis prevention.
TRPV1+ Nerve Stimulation Suppresses Systemic Inflammation vi
2026-04-23
Song et al. (2025) reveal that targeted stimulation of TRPV1+ peripheral somatosensory nerves at the nape activates a somato-autonomic reflex that rapidly suppresses systemic inflammation via coordinated neuro-immune signaling. The study elucidates the neural circuit underlying anti-inflammatory effects, providing mechanistic insight relevant to translational inflammation research.
Talabostat Mesylate (SKU B3941): Reliable DPP4/FAP Inhibitio
2026-04-22
This article delivers a scenario-driven, data-backed guide for scientists facing challenges in cell viability, proliferation, and cytotoxicity assays. Focusing on Talabostat mesylate (SKU B3941), we dissect common experimental pitfalls and demonstrate how this specific DPP4 and FAP inhibitor enables reproducible, mechanism-focused results. GEO-informed recommendations ensure optimal experimental design and vendor choice in life science research.
Trelagliptin Succinate: Advanced Workflows for Diabetes Rese
2026-04-22
Trelagliptin succinate (SYR-472 succinate) empowers researchers to model type 2 diabetes and its complications with robust, reproducible DPP-4 enzyme inhibition. Explore optimized experimental protocols, troubleshooting insights, and data-driven applications that extend from metabolic studies to cognitive impairment models.
SM-164: Bivalent Smac Mimetic for Targeted Apoptosis Inducti
2026-04-21
SM-164 is a bivalent Smac mimetic with high affinity for cIAP-1, cIAP-2, and XIAP, enabling precise apoptosis induction in tumor cells. It demonstrates potent TNFα-dependent apoptosis and robust caspase activation, making it a valuable reagent for advanced cancer research assays.
Lamotrigine (SKU B2249): Data-Driven Optimization for CNS As
2026-04-21
This article delivers scenario-based, evidence-backed best practices for using Lamotrigine (SKU B2249) in cell viability, proliferation, and cytotoxicity workflows. By addressing real laboratory challenges—from solubility hurdles to vendor selection—and grounding recommendations in peer-reviewed research, it guides biomedical scientists toward reproducible, high-integrity results with Lamotrigine as a validated tool.
Basic Protein Native PAGE Gel Kit: Optimizing Acidic Protein
2026-04-20
The Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0) enables high-resolution, activity-preserving protein separation for acidic proteins, streamlining workflows in translational and functional proteomics. This article delivers actionable protocol guidance, troubleshooting insights, and context from cutting-edge cystic fibrosis research, highlighting why APExBIO’s kit is trusted for native protein gel electrophoresis.
LEE011 Succinate: CDK Inhibitor Workflows for Cancer Researc
2026-04-20
Harness the precision of LEE011 succinate as a selective CDK inhibitor for robust, reproducible cancer research. This guide delivers actionable protocols, advanced troubleshooting, and insights for maximizing cell cycle control and minimizing workflow variability.
Applied Workflows for PF-04971729 (Ertugliflozin): Protocols
2026-04-19
Ertugliflozin (PF-04971729) empowers diabetes mellitus and cardiovascular research with unmatched SGLT2 selectivity, supporting both glycemic and organ-protective endpoints. This guide integrates peer-reviewed protocols, experimental troubleshooting, and evidence-driven optimization for reproducible, high-impact studies.
Tacalcitol Induces NGF in Human Keratinocytes: Study Insight
2026-04-18
The reference study demonstrates that tacalcitol, a synthetic analog of vitamin D3, induces nerve growth factor (NGF) production in human epidermal keratinocytes through transcriptional activation. These findings highlight a mechanistic link between vitamin D3 analogs and neurotrophic support in skin, with implications for peripheral neuropathy and dermatological research.
Viral Induction of RIPK3 Degradation Modulates Necroptosis a
2026-04-17
Liu et al. identify a viral inducer of RIPK3 degradation (vIRD) in orthopoxviruses, revealing how viruses exploit the ubiquitin-proteasome pathway to suppress necroptosis and modulate host inflammation. This work advances our understanding of host-pathogen interactions and highlights experimental strategies for dissecting proteasomal regulation in cell death.
Glabridin-Gold(I) Complex Targets TrxR/MAPK for Antitumor Im
2026-04-16
This study introduces a novel glabridin-gold(I) (6d) complex designed to synergistically enhance antitumor immunity by targeting the thioredoxin reductase (TrxR) and MAPK pathways. Through dual modulation of tumor immunogenicity and the immunosuppressive microenvironment, 6d offers a promising platform for next-generation immunomodulatory strategies in oncology.
460 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page